ColigoMed
Sunnyvale, US · Founded 2021 · Delaware corporation
Founders & leadership
SN
Sabhapathi Naidu AnnamaneniNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$1.8M disclosed across 1 round · 2023
▶$1.8MraisedFeb 2026 · 35 investors · Other TechnologyRule 506(b)
▶$1.8MraisedFeb 2026 · 35 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Sabhapathi Naidu AnnamaneniExecutive Officer, Director, Promoter
- Offering amount
- $2M
- Amount sold
- $1.8M
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has ColigoMed raised?
- ColigoMed has disclosed $1.8M raised across 1 round.
- Where is ColigoMed headquartered?
- ColigoMed is headquartered in Sunnyvale, US.